New Steps for Compliance: A Closer Look at the DOJ’s Revised Corporate Compliance Guide

Überblick


On June 1, 2020, the Criminal Division of the Department of Justice (DOJ) issued updates to its „Evaluation of Corporate Compliance Program“ guidance. This update reflects the agency’s evolving views on compliance program elements and activities, as well as the questions DOJ asks when assessing the effectiveness of an organization’s compliance program. It can also be useful for organizations in evaluating their own compliance program effectiveness.

This program, featuring insights from our white collar, healthcare, and corporate governance teams, will include:

  • Analysis of DOJ’s revised “Evaluation of Corporate Compliance Programs” guidance and the agency’s refined perspective
  • Practical implications for compliance officers, in-house counsel, and audit & compliance committees when evaluating and operating compliance programs
  • Other important developments relating to corporate compliance programs

We want to ensure we address the issues of most importance to our participants, and we encourage you to submit your questions for the panel in advance during registration.

Registration Information

12:00 pm – 1:00 pm (EST)

Zoom webinar.

Details sent upon registration.

Mehr erfahren

Webinar / Externe Vorträge / November 11, 2020

BVCA Healthcare Sector Digital Forum

Webinar / Externe Vorträge / October 28, 2020

FDLI: Advertising and Promotion for Medical Products Conference

Virtual Event / McDermott Event / October 20 - November 17, 2020

Life Sciences Dealmaking Symposium 2020

Webinar / Externe Vorträge / October 15, 2020

Boston Biotechnology Summit

ANSPRECHPARTNER